Growth Metrics

Edwards Lifesciences (EW) Long-Term Debt Repayments (2016 - 2022)

Edwards Lifesciences has reported Long-Term Debt Repayments over the past 12 years, most recently at $100000.0 for Q4 2022.

  • Quarterly results put Long-Term Debt Repayments at $100000.0 for Q4 2022, changed 0.0% from a year ago — trailing twelve months through Dec 2022 was $200000.0 (down 97.14% YoY), and the annual figure for FY2023 was $300000.0, up 50.0%.
  • Long-Term Debt Repayments for Q4 2022 was $100000.0 at Edwards Lifesciences, roughly flat from $100000.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for EW hit a ceiling of $601.2 million in Q4 2018 and a floor of -$8.7 million in Q3 2021.
  • Median Long-Term Debt Repayments over the past 5 years was $3.8 million (2019), compared with a mean of $65.5 million.
  • Biggest five-year swings in Long-Term Debt Repayments: skyrocketed 10635.71% in 2018 and later plummeted 495.45% in 2021.
  • Edwards Lifesciences' Long-Term Debt Repayments stood at $601.2 million in 2018, then crashed by 99.14% to $5.2 million in 2019, then plummeted by 42.31% to $3.0 million in 2020, then plummeted by 96.67% to $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022.
  • The last three reported values for Long-Term Debt Repayments were $100000.0 (Q4 2022), $100000.0 (Q2 2022), and $100000.0 (Q4 2021) per Business Quant data.